Literature DB >> 28878113

Documentation of Measles Elimination in Iran: Evidences from 2012 to 2014.

Manoochehr Karami1, Seyed Mohsen Zahraei2, Azam Sabouri2, Rambod Soltanshahi2, Azam Biderafsh3, Naser Piri4, Jong-Koo Lee5.   

Abstract

BACKGROUND: Documentation of achieving the goal of measles elimination to justify to international organizations including the WHO is a priority for public health authorities. This study aimed to address the status of Iran in the achievement of the measles elimination goal from 2012-2014. STUDY
DESIGN: A descriptive study
METHODS: Data on the measles outbreaks were extracted from the national notifiable measles surveillance system in Iran from 2012 to 2014. The required documents regarding the achievement of measles elimination, including Effective Reproduction Number (R) and the distribution of outbreak size, was addressed. The R was calculated using the proportion of imported cases as 1 - P, where P is equal to the proportion of cases that were imported. The distribution of the measles outbreaks size was described using descriptive statistics to show their magnitudes. The proportion of large outbreaks with more than 10 cases was considered as a proxy of the R value.
RESULTS: The total number of measles cases was 232 cases (including 186 outbreak related cases) in 2012 and 142 cases in 2014, including108 outbreak related cases. The distribution of the measles outbreak size of occurred outbreaks from that period indicated that there were 37 outbreaks with three or more than three cases. The R value in 2012 was 0.87 and the corresponding value for 2014 was 0.76.
CONCLUSIONS: According to the magnitude of effective reproduction number and distribution of outbreaks' size, measles has been eliminated in Iran. However, it is necessary to consider the potential endemic activity of measles because of no authorized immigration.

Keywords:  Elimination; Infectious Diseases; Iran; Measles; Reproductive number

Mesh:

Year:  2017        PMID: 28878113

Source DB:  PubMed          Journal:  J Res Health Sci        ISSN: 2228-7795


  8 in total

1.  Seroprevalence of antibodies to measles and rubella eight months after a vaccination campaign in the southeast of Iran.

Authors:  Shahrokh Izadi; Seyed Mohsen Zahraei; Talat Mokhtari-Azad
Journal:  Hum Vaccin Immunother       Date:  2018-02-26       Impact factor: 3.452

2.  A Nationwide Study on the Seroprevalence of Measles, Mumps, and Rubella in Iranian Children and Adolescents.

Authors:  Zary Nokhodian; Behrooz Ataei; Mohammad Mehdi Gouya; Shervin Ghaffari Hoseini; Majid Yaran; Marjan Mansourian; Mohammad Esmaeil Motlagh; Ramin Heshmat; Seyed Mohsen Zahraei; Roya Kelishadi
Journal:  Iran J Public Health       Date:  2022-02       Impact factor: 1.479

3.  Measles Elimination Successful and Its Relevant Challenges in Iran.

Authors:  Seyed Abbas Hosseinalipour; Abolfazl Mohammadbeigi; Siamak Mohebi; Abedin Saghafipour; Amin Arabshahi; Farzaneh Mahdianpour
Journal:  Int J Prev Med       Date:  2022-04-05

4.  Estimation of measles risk using the World Health Organization Measles Programmatic Risk Assessment Tool, Iran.

Authors:  Abolfazl Mohammadbeigi; Seyed Mohsen Zahraei; Azadeh Asgarian; Sima Afrashteh; Narges Mohammadsalehi; Salman Khazaei; Hossein Ansari
Journal:  Heliyon       Date:  2018-11-01

5.  Estimation of the Basic Reproduction Number and Vaccination Coverage of Influenza in the United States (2017-18).

Authors:  Roya Nikbakht; Mohammad Reza Baneshi; Abbas Bahrampour
Journal:  J Res Health Sci       Date:  2018-09-22

6.  Measles and rubella serosusceptibity among population vaccinated with different schedules: the potential impact on measles-rubella elimination in Iran.

Authors:  Hana Saffar; Maryam Khalifeloo; Mohammad-Jafar Saffar; Alireza Abdollahi; Mohammad-Reza Parsaei; Gholam-Reza Ghorbani; Samaneh Salarvand; Mohsen Aarabi
Journal:  BMC Infect Dis       Date:  2021-03-25       Impact factor: 3.090

7.  Seroconversion rates following 2 doses of measles- mumps- rubella vaccination given at the ages 12 and 18 months: data for possible additional dose at older age.

Authors:  Hana Saffar; Sayed Jaber Mousavi; Hiva Saffar; Mohammad-Reza Parsaei; Gholam-Reza Ghorbani; Mohammad Jafar Saffar
Journal:  BMC Immunol       Date:  2022-01-16       Impact factor: 3.615

8.  Monitoring of Surveillance Quality Indicators of Measles in Iranian Districts: Analysis of Measles Surveillance System 2014-2016.

Authors:  Seyed Mohsen Zahraei; Abolfazl Mohammadbeigi; Narges Mohammadsalehi; Azam Sabouri; Sima Afrashteh; Shahram Arsang Jang; Hossein Ansari; Salman Khazaei
Journal:  J Res Health Sci       Date:  2018-06-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.